Pharmacological Profiles of Oligomerized μ-Opioid Receptors
Opioids are widely prescribed pain relievers with multiple side effects and potential complications. They produce analgesia via G-protein-protein coupled receptors: μ-, δ-, κ-opioid and opioid receptor-like 1 receptors. Bivalent ligands targeted to the oligomerized opioid receptors might be the key...
Main Authors: | Ing-Kang Ho, Cynthia Wei-Sheng Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-10-01
|
Series: | Cells |
Subjects: | |
Online Access: | http://www.mdpi.com/2073-4409/2/4/689 |
Similar Items
-
RESEARCH OF INFLUENCE OF POLYMORPHISM Μ-OPIOID RECEPTOR GENE ON THE TOTAL INTRAVENOUS ANAESTHESIA
by: O. A. Maharin, et al.
Published: (2014-03-01) -
Methamphetamine-induced changes in the striatal dopamine pathway in μ-opioid receptor knockout mice
by: Park Sang Won, et al.
Published: (2011-11-01) -
Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors
by: Adriano Mollica, et al.
Published: (2017-01-01) -
Role for μ-opioid receptor in antidepressant effects of δ-opioid receptor agonist KNT-127
by: Yuki Moriya, et al.
Published: (2023-03-01) -
Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist–Neurokinin Antagonist Peptidomimetics
by: Charlène Gadais, et al.
Published: (2021-09-01)